Eugene Paul Kroeff

Title: The Innovations of Eugene Paul Kroeff

Introduction

Eugene Paul Kroeff is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the purification of cyclopeptide compounds. His work has implications for the production of important medicinal compounds.

Latest Patents

Kroeff holds a patent for the "Purification of Echinocandin cyclopeptide compounds." This patent describes a method for separating and purifying various fermentation cyclopeptide products that contain at least one protonatable amino group. The process involves adsorbing the mixture onto hydrophobic, reversed phase chromatographic media and eluting it with a continuous linear acetic acid gradient. This innovative method also includes a process for removing tripeptide-aldehyde by-products from fermentation products using a derivatizing agent.

Career Highlights

Eugene Paul Kroeff is associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to contribute to advancements in drug development and purification processes. His expertise in cyclopeptide compounds has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Kroeff has collaborated with notable colleagues such as John Robert Dobbins and Jeffrey Thomas Vicenzi. These collaborations have likely enhanced the research and development efforts within their projects.

Conclusion

Eugene Paul Kroeff's innovative work in the purification of cyclopeptide compounds showcases his significant contributions to the pharmaceutical field. His patent and collaborations reflect his commitment to advancing medicinal chemistry.